Skip to main content

Want a detailed portfolio tracker?

THRD
NASDAQ
$5.38

Third Harmonic Bio Inc (THRD)

Third Harmonic Bio Inc. is an innovative biotechnology company dedicated to advancing breakthrough therapies for severe immunological and inflammatory disorders. Utilizing its proprietary genetic engineering platform, the firm is developing a robust pipeline of drug candidates designed to address significant unmet medical needs within the biopharmaceutical sector. With a strong emphasis on scientific rigor and patient-centric solutions, Third Harmonic Bio is strategically positioned to transform treatment paradigms and enhance the quality of care for patients and healthcare providers alike.
Website: https://www.thirdharmonicbio.com
Sector:
Healthcare
Industry:
Biotechnology
Target: $3 (-44.24%)

Market Cap

$242M

P/B Ratio

0.89

Free Cash Flow Yield

-17.24%

Beta (5Y)

0.50

Price Chart

Valuation
Market Cap$242M
P/B0.89
Profitability
EBITDA-$66M
EPS-$1.22
Financial Health
Free Cash Flow Yield-17.24%
Growth & Risk
Beta (5Y)0.50
Sharpe Ratio-3.63